Home / Tenofovir Disoproxil and Emtricitabine / Italy
IT ATC J05AR03 · updated 2 Nov 2026
Tenofovir Disoproxil and Emtricitabine shortage in Italy
Is there a Tenofovir Disoproxil and Emtricitabine shortage in Italy?
Yes. As of 2 Nov 2026, 3 Tenofovir Disoproxil and Emtricitabine products are reported short in Italy, the first since 1 Oct 2024. The company estimate for the return is 30 Nov 2026. Main reason: manufacturing problem.
Also short in Canada, Austria, Belgium, Sweden. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | EMTRICITABINA/TENOFOVIR DISOPROXIL MYLAN discontinuation | MYLAN PHARMACEUTICALS LIMITED | 1 Oct 2024 | not given | Manufacturing problem Problemi produttivi |
| IT | EMTRICITABINA E TENOFOVIR DISOPROXIL TEVA | TEVA ITALIA S.R.L. | 15 Apr 2026 | 30 Nov 2026 | Manufacturing problem Problemi produttivi |
| IT | EMTRICITABINA E TENOFOVIR DISOPROXIL AUROBINDO discontinuation | AUROBINDO PHARMA (ITALIA) S.R.L. | 25 Oct 2026 | not given | Increased demand Elevata richiesta |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.